MDM2 represents one of the most important negative regulators of p53 and overexpression of MDM2 or inactivation of ARF (p14) are the main mechanisms of functional inactivation of p53 in TP53-unmutated AML patients. The gene discussed is MDM2; the disease is acute myeloid leukemia.